STORY sOURCE: University of Iowa Health Science Relations, 5139 Westlawn, Iowa City, Iowa 52242-1178source: David Pedersen University of IowaOptherion, a University of Iowa Research Foundation licensee and a company developing products for the diagnosis and treatment of age-related macular degeneration and other chronic diseases, announced that it completed $ 37,000 start-up funding.
Colin J. Optherion president and CEO, said: ‘We are delighted with the high quality of the investors, is is on the series A financing. ‘Foster the former CEO of Bayer Pharmaceuticals in the U.S. And region Head for Bayer Pharmaceuticals in North America.It now one study of Danny Chan, a at the look at of ‘body – clock’ the mechanism which controls all biological processes, such as sleep, excitation, blood pressure and cardiac frequency. – Danny said. ‘Many diseases are point fluctuations in during 24 hours, specifically heart diseases like heart attacks are frequently between 6.00 to 12 clock.